Boston Scientific Corp. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares fell 1.08% to $44.81 on Wednesday, underperforming the broader market and its medical device peers like Abbott, Medtronic, and Stryker during a grim trading session. The stock remains significantly below its 52-week high of $109.50. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) slid 1.08% to $44.81 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.28% to 7,482.71 and Dow Jones Industrial Average falling 1.09% to 52,348.39.
Boston Scientific Corp. closed 59.08% short of its 52-week high of $109.50, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Abbott Laboratories (ABT) fell 0.69% to $95.18, Medtronic PLC (MDT) fell 2.17% to $82.01, and Stryker Corp. (SYK) fell 0.88% to $326.85.
Trading volume (13.5 M) remained 7.7 million below its 50-day average volume of 21.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-08-26 1644ET